Gene Query: CLNS1A

Dataset Description Geneva Score
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 38.69
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 38.69
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 34.5
RNAseq analysis of ESRP regulated splicing events in prostate cancer 33.83
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 33.11
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 31.97
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 30.78
Peptidomimetic blockade of MYB in acute myeloid leukemia 30.78
Developmental stage specific chromosome architecture in human erythroid cells 29.67
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 29.67
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 28.07
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 27.63
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 27.33
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 25.72
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 24.5
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 23.41
RNAseq of HEK293 cells after Chtop knockdown 22.97
Co-transcriptional loading of RNA export factors shapes the human transcriptome 22.97
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 21.68
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 21.29
Dtx3L and Androgen Signaling in Prostate Cancer 20.54
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 20.03
N6-methyladenine DNA Modification in Glioblastoma 20.03
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 18.72
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 18.72
Differetially expressed genes after hTR overexpression in U2OS cells 18.04
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 17.52
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 17.52
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 17.25
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 17.15
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 16.98
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 16.86
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 16.86
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 16.68
3’ Uridylation Expands miRNA Target Repertoire 15.88
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 15.39
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 15.25
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 15.21
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 15.21
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 14.58
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 14.42
Transcriptional changes in lymphoma cells induced by LSD1 depletion 13.68
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 13.68
UBC9 knockdown in bladder cancer T24 cell lines 13.65
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 13.34
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 13.34
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 13.3
Global analysis of enhancer targets: Mosaic-seq 13.14
Genome wide expression change by RNF168 knocking down in NEC cells 12.87
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 12.69
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 12.67
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 12.67
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 12.57
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 12.36
Identification of global regulators of T-helper cell lineage specification 12.36
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 12.27
Glioblastoma stem cells infected by ZIKA virus 12.11
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 12.09
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 12.08
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 12.06
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 12.02
RNA-seq analysis of AML cells in response to ASLAN003 11.95
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 11.77
Nucleoporin-mediated regulation of cell identity genes 11.71
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 11.66
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.65
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 11.63
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 11.57
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 11.54
Zika infected neural stem cells 11.44
Transcriptome analysis of Zika infected neural stem cells 11.44
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 11.38
The landscape of alternative splicing in aggressive prostate cancers 11.35
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 11.27
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 11.22
Paxillin regulates genomic networks in prostate cancer [LNCaP] 11.04
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 11.02
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 10.89
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 10.88
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 10.88
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 10.78
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 10.76
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 10.76
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 10.66
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 10.66
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.63
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.6
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.6
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.59
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 10.58
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 10.57
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 10.56
hnRNP C is a key regulator of protein synthesis in mitosis 10.46
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 10.45
Mitochondrial dsRNA triggers antiviral signalling in humans 10.44
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 10.4
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 10.39
RNA-sequencing of human liver tissue 10.31
RNA-seq analysis of differentiating human erythroblasts 10.21
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 10.19
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 10.18
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 10.17
CROP-Seq in Primary Human T Cells 10.09
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 9.97
Identification of the role of polydom in neurofibromas 9.85
The comparison of high-throughput single-cell RNA-seq methods 9.73
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 9.69
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.65
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.6
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.6
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 9.5
MCF10A H-Ras RNA-Seq 9.5
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 9.47
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 9.47
ETV7 and interferon response 9.47
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 9.47
RNA-seq of YB5 cells treated with Proscillaridin A 9.41
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 9.4
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.35
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 9.27
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 9.27
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 9.27
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 9.24
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 9.17
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 9.16
Differentially expressed vascular development genes for iPSC-ECs from CDI 9.13
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.11
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 9.04
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 9.03
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.0
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 8.98
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 8.98
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 8.98
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 8.91
Effect of FGF13 depletion on the H460 cell line 8.89
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.88
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 8.85
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 8.84
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 8.83
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 8.81
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 8.81
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 8.77
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 8.77
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.76
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.76
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 8.76
Gene expression in PANC1 cells treated with Rakicidin 8.75
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 8.73
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 8.73
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.66
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.59
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.57
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 8.54
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 8.54
Functional role of SLIT2 and ROBO1 in trophoblasts 8.47
MYC dependent mRNA translation shapes gene expression and cell biology 8.46
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 8.44
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.32
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 8.3
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 8.2
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 8.2
IDH3a KO RNA-seq 8.19
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 8.17
Transcriptional effect of ETV1 knockdown in melanoma cells 8.15
HNF1A deficiency impairs β-cell fate, granule maturation and function 8.03
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 7.98
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 7.98
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 7.97
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 7.97
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.91
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.91
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 7.89
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 7.85
U1 snRNP telescripting regulates size-function stratified human genome 7.84
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 7.83
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.76
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 7.76
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 7.75
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 7.75
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.75
Identifying the molecular mode of action of itraconazole in colorectal cancer 7.74
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.7
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 7.69
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 7.67
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 7.65
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 7.65
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 7.61
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.58
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 7.57
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.54
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.5
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 7.49
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 7.33
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 7.32
Effect of Influenza virus infection on lncRNA expression in A549 cells 7.3
Survival of pancreatic cancer cells lacking KRAS function 7.29
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 7.26
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 7.23
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 7.17
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 7.16
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 7.15
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.1
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 7.09
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 7.07
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 7.03
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.02
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 7.02
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 7.01
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 7.01
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.0
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.0
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 6.96
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 6.94
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 6.94
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 6.91
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.91
RIG-I and MDA5 fRIP during KSHV lytic reactivation 6.88
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.88
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.88
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 6.88
RNA-Seq with and without RNase treatment in PCa cell lines 6.8
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.77
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.76
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.76
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.73
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.72
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.71
MYCi975 regulates MYC target genes 6.71
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.7
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.7
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 6.7
Sensing self and nonself circular RNAs 6.69
METTL3 and WTAP 6.67
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.65
Transcriptomic analyssis following EHMT1/2 inhibition 6.64
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.64
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.61
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.61
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 6.56
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 6.56
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 6.53
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 6.52
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 6.52
Human cell line and subcutaneous tumor 6.5
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.44
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.42
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.38
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.38
Downregulation of DDX5/DDX17 and REST 6.36
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 6.36
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 6.33
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.29
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 6.29
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.28
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.26
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.26
K562 polyA RNA-Seq 6.21
Cajal bodies are linked to genome conformation [RNA-Seq] 6.17
Cajal bodies are linked to genome conformation 6.17
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 6.16
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 6.0
SLAM-seq for K562 endogenous mRNA decay 5.97
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 5.96
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.95
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 5.92
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 5.9
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 5.89
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.87
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 5.86
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 5.86
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.71
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 5.69
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 5.69
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.69
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.69
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.64
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 5.61
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 5.59
mRNA expression in human DAOY cells 5.59
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.5
SLIGRL-induced gene expression changes in NHEK cells 5.5
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 5.46
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 5.43
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.39
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 5.39
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 5.36
Endometrial transcriptome and PGR cistrome in cycling fertile women 5.36
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 5.35
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.13
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 5.11
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 5.11
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.1
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 5.1
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 5.1
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 5.02
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 5.01
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 4.99
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 4.96
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.94
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.9
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.9
Human HAP1 cells before and after nutrient deprivation 4.87
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 4.87
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.79
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.79
Generation and persistence of human tissue-resident memory T cells in lung transplantation 4.78
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.76
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 4.74
RNA-seq of IL-4 stimulated human keratinocytes 4.69
RNA-sequencing in immortalized human mammary epithelial cells 4.68
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 4.68
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.67
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.61
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 4.59
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 4.59
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 4.58
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.58
RNA sequencing of human mammary epithelial cells 4.55
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.55
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 4.53
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.5
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.5
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.5
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 4.46
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 4.44
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 4.42
Triple vectors expand AAV transfer capacity in the retina 4.3
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.25
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 4.2
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.18
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.13
RNA-seq of RKO cells with cTAZ KO or putback 4.11
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.99
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.99
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 3.97
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 3.97
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 3.95
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.89
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 3.71
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.65
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.54
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.54
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.5
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.5
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.49
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.48
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.44
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.42
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.41
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.4
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.39
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.39
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.34
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.29
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.28
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.28
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.21
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.21
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.21
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.19
RNA-Seq of PRMT1 overexpression ECA109 cells 3.17
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 3.16
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.06
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.05
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.98
Differential gene expression profiles in imatinib-resistant cell lines 2.9
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.87
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.87
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 2.83
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 2.83
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 2.81
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.72
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 2.67
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 2.63
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.61
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.6
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.59
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 2.58
Human Treg IL-12 stimulation 2.56
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.53
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.53
p63 controls the enhancer landscape during keratinocyte differentiation 2.52
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.46
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 2.45
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 2.45
Random mono-allelic expression in MECP2-mutated cells 2.38
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.34
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.3
Comparative Analysis of Cas9 Activators Across Multiple Species 2.3
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.27
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.25
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.18
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.16
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 2.11
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.02
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 2.0
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.99
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.96
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 1.95
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.94
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.93
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.91
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 1.89
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.88
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.85
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.85
Induced DNA demethylation, genome instability and transcription 1.74
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.74
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 1.66
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.65
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.65
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.64
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 1.63
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.63
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.62
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.61
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.6
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.53
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.49
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 1.47
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.43
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.43
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.37
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.37
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 1.32
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.32
MARCKS and lnc-MARCKS act as inflammation regulators 1.28
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.26
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.26
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.25
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.21
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.18
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.16
Hepatic transcriptome of pediatric hepatoblastoma. 1.16
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.16
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.14
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.13
Impact on erythroid progenitor type on erythroid differntiation 1.11
Discovering human diabetes-risk gene function with genetics and physiological assays 1.07
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.06
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.04
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.04
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 1.03
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.99
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.98
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.98
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.98
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.97
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.94
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.9
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.89
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.88
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.88
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.84
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.83
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 0.8
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.79
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.75
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.75
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.71
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.64
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.64
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.63
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.63
Total RNA-Seq data from leukemic patients with complex structural variants 0.62
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.61
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.6
RNA-Seq from human ILC transitional populations 0.6
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.59
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 0.59
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.58
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.58
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.58
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.57
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.52
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.5
RNA-seq data 0.48
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 0.47
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.46
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.44
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.4
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.4
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.39
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.34
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.33
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.3
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.29
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.29
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.26
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.16
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.16
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.16
siRNA-mediated knockdown 0.14
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.1
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.09
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.08
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.06
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation